MedTrace Logo

Adenocarcinoma of the Uterine Cervix and HPV

NCT05267834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2023-03-24

No results posted yet for this study

Summary

The present study will mainly aim to review and characterize the pathologic features, treatment options, and follow-up outcomes of women with in situ/microinvasive adenocarcinoma of the uterine cervix according to HPV status (positive versus negative high-risk HPV). It will evaluate the impact of HPV status on the recurrence and survival during a follow-up of five years. The present study will be a multi-institutional study including several oncological Italian Centers. Data will be retrospectively collected from January 2012 to December 2016 with a total follow-up of 5 years.

Conditions

  • Adenocarcinoma of the Uterine Cervix

Interventions

PROCEDURE

Conization and/or Hysterectomy

Women undergoing cervical conization or simple/modified/radical hysterectomy with or without pelvic lymphadenectomy

Sponsors & Collaborators

  • Università Politecnica delle Marche

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2023-03-01
Completion
2023-03-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05267834 on ClinicalTrials.gov